From April 1, 2024 to April 23, 2024, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 49,999,929 shares, representing 6.59% for CNY 322.09 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.75 CNY | +2.50% | +4.17% | -16.67% |
1st Jan change | Capi. | |
---|---|---|
-16.67% | 570M | |
+21.01% | 43.7B | |
+29.65% | 23.11B | |
+19.45% | 14.31B | |
+55.92% | 12.87B | |
-0.05% | 6.79B | |
-11.27% | 6.45B | |
-8.87% | 5.73B | |
+12.21% | 5.55B | |
+9.49% | 4.81B |
- Stock Market
- Equities
- 600351 Stock
- News Yabao Pharmaceutical Group Co., Ltd
- Tranche Update on Yabao Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on May 9, 2023.